Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Overview
{googletagmanager_body} Grozs Countries/Valstis polish english german hungarian ukrainian latvian czech slovak lithuanian serbian Produkti Prieks PDF Katalogs Arhitektiem Jaunumi Izpārdošana Akcijas Mēs Firmas rekvizīti Kontakti Vēsture Jūs esiet šeit: Galvenā lapa > Firmas rekvizītiLietotājs: Nepievienoties Merida-Latvija Riga, Nautrenu 12 tel.
News
Eli Lilly to Acquire Merida Biosciences for $2.8 Billion PharmExec
Eli Lilly has agreed to acquire Merida Biosciences for up to $2.875 billion to gain a precision autoantibody degradation platform led by MER511.
Read more
Report
Merida Lithos 8000 review: superb suspension and natural handling make this one of the best eMTBs you can buy
The Lithos is exceptionally composed, confidence-inspiring and comfortable
Read more
Report
Lilly to acquire biotech firm Merida in $2.87bn deal
Eli Lilly will acquire Merida Biosciences for up to $2.875 billion, gaining MER511, a Phase I therapy targeting autoantibodies in Graves
Read more
Report
Lilly To Acquire Merida Biosciences For Up To $2.875 Billion To Expand Precision Autoimmune And Allergy Pipeline
Eli Lilly and Company has agreed to acquire Merida Biosciences for up to $2.875 billion in cash, adding a precision immunology platform designed to selectively eliminate disease-causing antibodies across autoimmune and allergic conditions.
Read more
Report
Pro access
Upgrade to see all 7 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.